Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TU-100 for Postoperative Ileus
NCT00266461Phase 2Completed
- Sponsor
- Tsumura & Co.
- Start
- Dec 2005
- Primary completion
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of daikenchuto in postoperative ileus (POI) (3 arms), sponsored by Tsumura & Co. Primary endpoint: Incidence of Adverse Events up to 10 days. Started Dec 2005; status: completed.
02
Drugs
daikenchuto
03
Conditions
postoperative ileus (POI)
Beyond the preview
Go deeper on NCT00266461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00266461.